PTC Therapeutics
PTCT
#2677
Rank
A$9.45 B
Marketcap
A$117.81
Share price
0.42%
Change (1 day)
61.68%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: A$9.45 Billion

As of December 2025 PTC Therapeutics has a market cap of A$9.45 Billion. This makes PTC Therapeutics the world's 2677th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025A$9.45 B68.65%
2024A$5.60 B83.72%
2023A$3.05 B-25.42%
2022A$4.09 B5.39%
2021A$3.88 B-28.28%
2020A$5.41 B27.47%
2019A$4.24 B72.34%
2018A$2.46 B178.12%
2017A$0.88 B70.66%
2016A$0.51 B-65.57%
2015A$1.50 B-27.52%
2014A$2.08 B359.54%
2013A$0.45 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of PTC Therapeutics was reported to be:

A$9.45 Billion
by Nasdaq info icon info icon
A$9.45 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Vertex Pharmaceuticals
VRTX
A$176.21 B 1,763.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$3.32 B-64.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.18 B-98.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
A$16.24 B 71.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.70 B-82.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$392.12 B 4,045.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland